Cargando…
Protection against highly pathogenic SIV by BCG-SIV recombinant priming and attenuated replicating vaccinia-SIV recombinant boosting
Autores principales: | Zhang, X, Sakawaki, H, Miura, T, Igarashi, T, Horibata, S, Yokomizo, K, Matsuo, K, Yamamoto, N, Fofana, IB, Johnson, W, Ohashi, T, Shida, H |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3442035/ http://dx.doi.org/10.1186/1742-4690-9-S2-P39 |
Ejemplares similares
-
CD8 T Cells Show Protection against Highly Pathogenic Simian Immunodeficiency Virus (SIV) after Vaccination with SIV Gene-Expressing BCG Prime and Vaccinia Virus/Sendai Virus Vector Boosts
por: Kato, Seiichi, et al.
Publicado: (2021) -
A recombinant attenuated Mycobacterium tuberculosis-SIV combination vaccine is safe and immunogenic in immunocompromised, SIV-infected infant macaques
por: Jensen, K, et al.
Publicado: (2012) -
Mucosal prime with a replicating vaccinia-based vaccine promotes mucosal immunity against SIV
por: Tang, X, et al.
Publicado: (2012) -
GCM-SIV1.5: Optimal Tradeoff between GCM-SIV1 and GCM-SIV2
por: Zhang, Ping
Publicado: (2023) -
SIV replication in human cells
por: Sakuma, Ryuta, et al.
Publicado: (2012)